212 related articles for article (PubMed ID: 18193826)
1. New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations.
Moulin A; Demange L; Ryan J; Mousseaux D; Sanchez P; Bergé G; Gagne D; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J
J Med Chem; 2008 Feb; 51(3):689-93. PubMed ID: 18193826
[TBL] [Abstract][Full Text] [Related]
2. Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations.
Moulin A; Demange L; Bergé G; Gagne D; Ryan J; Mousseaux D; Heitz A; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J
J Med Chem; 2007 Nov; 50(23):5790-806. PubMed ID: 17927165
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.
Demange L; Boeglin D; Moulin A; Mousseaux D; Ryan J; Bergé G; Gagne D; Heitz A; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J
J Med Chem; 2007 Apr; 50(8):1939-57. PubMed ID: 17375904
[TBL] [Abstract][Full Text] [Related]
4. New trisubstituted 1,2,4-triazoles as ghrelin receptor antagonists.
Blayo AL; Maingot M; Aicher B; M'Kadmi C; Schmidt P; Müller G; Teifel M; Günther E; Gagne D; Denoyelle S; Martinez J; Fehrentz JA
Bioorg Med Chem Lett; 2015 Jan; 25(1):20-4. PubMed ID: 25435152
[TBL] [Abstract][Full Text] [Related]
5. Trisubstituted 1,2,4-triazoles as ligands for the ghrelin receptor: on the significance of the orientation and substitution at position 3.
Moulin A; Demange L; Ryan J; M'Kadmi C; Galleyrand JC; Martinez J; Fehrentz JA
Bioorg Med Chem Lett; 2008 Jan; 18(1):164-8. PubMed ID: 18023181
[TBL] [Abstract][Full Text] [Related]
6. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.
Rudolph J; Esler WP; O'connor S; Coish PD; Wickens PL; Brands M; Bierer DE; Bloomquist BT; Bondar G; Chen L; Chuang CY; Claus TH; Fathi Z; Fu W; Khire UR; Kristie JA; Liu XG; Lowe DB; McClure AC; Michels M; Ortiz AA; Ramsden PD; Schoenleber RW; Shelekhin TE; Vakalopoulos A; Tang W; Wang L; Yi L; Gardell SJ; Livingston JN; Sweet LJ; Bullock WH
J Med Chem; 2007 Oct; 50(21):5202-16. PubMed ID: 17887659
[TBL] [Abstract][Full Text] [Related]
7. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone secretagogue receptor antagonists.
Costantino L
Expert Opin Ther Pat; 2012 Jun; 22(6):697-700. PubMed ID: 22537050
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new benzoxazinone derivatives as neuropeptide Y5 antagonists for the treatment of obesity.
Torrens A; Mas J; Port A; Castrillo JA; Sanfeliu O; Guitart X; Dordal A; Romero G; Fisas MA; Sánchez E; Hernández E; Pérez P; Pérez R; Buschmann H
J Med Chem; 2005 Mar; 48(6):2080-92. PubMed ID: 15771450
[TBL] [Abstract][Full Text] [Related]
10. Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.
Pasternak A; Goble SD; deJesus RK; Hreniuk DL; Chung CC; Tota MR; Mazur P; Feighner SD; Howard AD; Mills SG; Yang L
Bioorg Med Chem Lett; 2009 Nov; 19(21):6237-40. PubMed ID: 19767208
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a beta-MSH-derived MC-4R selective agonist.
Mayer JP; Hsiung HM; Flora DB; Edwards P; Smith DP; Zhang XY; Gadski RA; Heiman ML; Hertel JL; Emmerson PJ; Husain S; O'brien TP; Kahl SD; Smiley DL; Zhang L; Dimarchi RD; Yan LZ
J Med Chem; 2005 May; 48(9):3095-8. PubMed ID: 15857110
[TBL] [Abstract][Full Text] [Related]
12. Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.
Yu M; Lizarzaburu M; Beckmann H; Connors R; Dai K; Haller K; Li C; Liang L; Lindstrom M; Ma J; Motani A; Wanska M; Zhang A; Li L; Medina JC
Bioorg Med Chem Lett; 2010 Mar; 20(5):1758-62. PubMed ID: 20137933
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists.
Gillman KW; Higgins MA; Poindexter GS; Browning M; Clarke WJ; Flowers S; Grace JE; Hogan JB; McGovern RT; Iben LG; Mattson GK; Ortiz A; Rassnick S; Russell JW; Antal-Zimanyi I
Bioorg Med Chem; 2006 Aug; 14(16):5517-26. PubMed ID: 16697206
[TBL] [Abstract][Full Text] [Related]
15. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.
Xin Z; Serby MD; Zhao H; Kosogof C; Szczepankiewicz BG; Liu M; Liu B; Hutchins CW; Sarris KA; Hoff ED; Falls HD; Lin CW; Ogiela CA; Collins CA; Brune ME; Bush EN; Droz BA; Fey TA; Knourek-Segel VE; Shapiro R; Jacobson PB; Beno DW; Turner TM; Sham HL; Liu G
J Med Chem; 2006 Jul; 49(15):4459-69. PubMed ID: 16854051
[TBL] [Abstract][Full Text] [Related]
16. Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors (WO2012035124): a patent evaluation.
Costantino L
Expert Opin Ther Pat; 2012 Sep; 22(9):1099-104. PubMed ID: 22809244
[TBL] [Abstract][Full Text] [Related]
17. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats.
Salomé N; Haage D; Perrissoud D; Moulin A; Demange L; Egecioglu E; Fehrentz JA; Martinez J; Dickson SL
Eur J Pharmacol; 2009 Jun; 612(1-3):167-73. PubMed ID: 19356720
[TBL] [Abstract][Full Text] [Related]
18. Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents.
Alvarado M; Goya P; Macías-González M; Pavón FJ; Serrano A; Jagerovic N; Elguero J; Gutiérrez-Rodríguez A; García-Granda S; Suardíaz M; Rodríguez de Fonseca F
Bioorg Med Chem; 2008 Dec; 16(23):10098-105. PubMed ID: 18952442
[TBL] [Abstract][Full Text] [Related]
19. Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.
Lumb KJ; DeCarr LB; Milardo LF; Mays MR; Buckholz TM; Fisk SE; Pellegrino CM; Ortiz AA; Mahle CD
J Med Chem; 2007 May; 50(9):2264-8. PubMed ID: 17425299
[TBL] [Abstract][Full Text] [Related]
20. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
Serby MD; Zhao H; Szczepankiewicz BG; Kosogof C; Xin Z; Liu B; Liu M; Nelson LT; Kaszubska W; Falls HD; Schaefer V; Bush EN; Shapiro R; Droz BA; Knourek-Segel VE; Fey TA; Brune ME; Beno DW; Turner TM; Collins CA; Jacobson PB; Sham HL; Liu G
J Med Chem; 2006 Apr; 49(8):2568-78. PubMed ID: 16610800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
